Research Focus: How can we help childhood cancer survivors get active?
Promoting physical activity in childhood cancer survivors: Using qualitative and co-design methods to inform the development of an evidence-based intervention.
Exercise pathways in paediatric oncology, from hospital to school
Dr Peter Wright, Hayley Marriott and Dr Alba Solera-Sanchez, researchers at Oxford Brookes University, explain the benefits of staying physically active during and after treatment and explore how we can work collaboratively to improve physical activity pathways and support for children and young people.
How my cancer journey fuelled my strength and determination to succeed in sport
Jake Heasman was diagnosed with a brain tumour when he was two years old, leaving him visually impaired. He tells us how his experiences of cancer helped drive him on to sporting success.
Ask the expert: Dr Ren Manias
Ask the expert with Dr Ren Manias, Consultant Paediatric Oncologist at Southampton General Hospital, and Contact's medical adviser
How we tripled survival and reduced toxicity for children with liver cancer
Dr Peppy Brock is a retired consultant paediatric oncologist. She explains how a dedicated international group of medical professionals helped improve survival and reduce toxicity for a very rare type of childhood cancer.
Sharing knowledge and best practices: Starting blocks for progress and innovation
The European Society for Paediatric Oncology (SIOP Europe) is the only pan-European organisation representing all professionals working in the field of childhood cancers. Annika Strasser, SIOP Europe Communication and Marketing Coordinator, tells us about how it fosters partnerships that are helping to push progress across international boundaries.
Overcoming barriers to researching rare tumours
Dr Sara Stoneham is a paediatric oncology consultant at University College London Hospitals. Here, she explains some of the barriers to researching rare tumours and what can be done to overcome them.
Using super-fit immune cells to seek and destroy bone cancer
At the Fisher Lab at UCL, we are trying to find a better treatment that specifically attacks osteosarcoma cells, to better fight cancer and reduce the burden of side effects. We think that immunotherapy could be the right treatment because it trains cells from the immune system, called T Cells, to fight cancer and has been very successful in other cancers.
When life turns full circle: Using my experiences to help others
Dr Oscar Oglina was diagnosed with stage three liver cancer aged four. Now 24, he tells us how his experiences shaped his life and career path.